Clinical Trials Browser

Fanconi Anemia, Complementation Group D1, Carcinoma, Ovarian Epithelial, Breast Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Ewing, Small Cell Lung Carcinoma

NCT01339650 2018-01-02

Study of ABT-767 in Subjects With Breast Cancer 1 and Breast Cancer 2 (BRCA 1 and BRCA 2) Mutations and Solid Tumors or High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Phase 1 Completed

93 enrolled

Classical hematology

Fanconi Anemia, Complementation Group D1

NCT00419510 2016-08-17

Genetic Counseling in African American Women

Phase NA Completed

204 enrolled

BreastClassical hematologyGynecologic

Fanconi Anemia, Complementation Group D1, Breast Neoplasms, Ovarian Neoplasms

NCT00580021 2016-01-28

Clinical Outcomes in Hereditary Cancer

Withdrawn

BreastClassical hematologyGastrointestinal

Fanconi Anemia, Complementation Group D1, Breast Neoplasms, Pancreatic Neoplasms

NCT00776958 2014-07-31

Lynne Cohen Consortium Project: Multi-Center Database/Registry

Completed

176 enrolled

BreastClassical hematologyGynecologic

Fanconi Anemia, Complementation Group D1, Breast Neoplasms, Neoplasms, Ovarian Neoplasms

NCT00413491 2014-05-20

MR BRCA

Phase 4 Unknown

300 enrolled

BreastClassical hematology

Fanconi Anemia, Complementation Group D1, Breast Neoplasms

NCT01772979 2013-01-21

MITO15

Phase 2 Unknown

100 enrolled

Classical hematologyGynecologic

Fanconi Anemia, Complementation Group D1, Ovarian Neoplasms

NCT00165152 2012-08-09

Counseling Interventions for BRCA 1/2 Cancer Susceptibility Testing

Phase NA Completed

150 enrolled

BreastClassical hematologyGynecologic

Fanconi Anemia, Complementation Group D1, Breast Neoplasms, Ovarian Neoplasms

NCT00509509 2012-05-24

High Risk Breast Cancer Screening Program

Unknown

BreastClassical hematology

Breast Cancer, Familial, Fanconi Anemia, Complementation Group D1, Breast Neoplasms

NCT00155896 2005-09-12

Establishing the Incidences of BRCA1 and BRCA2 Mutation by Combining DHPLC and Direct Sequencing in Ovarian Cancer

Unknown

100 enrolled

Classical hematologyGynecologic

Fanconi Anemia, Complementation Group D1, Ovarian Neoplasms

Clinical Trials

Olaparib In Metastatic Breast Cancer

Assessment of Efficacy of AZD2281 in Platinum Sensitive Relapsed Serous Ovarian Cancer

A Study to Assess the Safety and Pharmacokinetics of an Inhibitor of Poly ADP-Ribose Polymerase-1 (PARP)

ICEBERG 1

C-PATROL

LUSTIC

ZENSHIN

Methods in Education for Breast Cancer Genetics

ICEBERG 3

REVIVAL

Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors

Study of ABT-767 in Subjects With Breast Cancer 1 and Breast Cancer 2 (BRCA 1 and BRCA 2) Mutations and Solid Tumors or High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Genetic Counseling in African American Women

Clinical Outcomes in Hereditary Cancer

Lynne Cohen Consortium Project: Multi-Center Database/Registry

MR BRCA

MITO15

Counseling Interventions for BRCA 1/2 Cancer Susceptibility Testing

High Risk Breast Cancer Screening Program

Establishing the Incidences of BRCA1 and BRCA2 Mutation by Combining DHPLC and Direct Sequencing in Ovarian Cancer